Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction

Recruiting now · Not applicable

Conditions studied: Myopia

In brief

Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.

Key facts

Study ID

NCT06788418

Run by

Beijing Visionly Plus Eye Hospital

People needed

1000

Starts

2025-01-20

Expected to finish

2025-12-31

Last updated by the study team

2025-01-23

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18-40 years
• Spherical equivalent of -1.00 to -10.00 D
• Stable refraction for at least 12 months
• Informed consent provided

You may not qualify if…

• Other ocular pathologies
• Previous refractive surgery
• Pregnancy or nursing
• Autoimmune or connective tissue disorders

Where it is running

• Beijing New Vision Eye Hospital — Beijing, China (enrolling)
• Beijing Visionly Plus Eye Hospital — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.